| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |